CNTNAP2 and autoimmune encephalitis: The cohort study by Hongzhi Guan’s team revealed that 12.5% of patients with ACA present autoimmune encephalitis mediated by neuronal surface antibodies, such as anti-NMDAR, anti-CasPR2, anti-DPPX, and anti-GABAR (5).